Manage your formulary budget
Drug patents …
… from Kazakhstan to Kalamazoo
Find generic entry opportunities
Anticipate generic drug launch
Proactively manage your pharmacy inventory
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
|Title:||3,4-Dihydrocarbostyril derivatives and a process for preparing the same|
|Abstract:||A novel compound represented by the formula ##SPC1## Wherein R is defined as hereinafter, having a blocking activity on .beta.-adrenergic nerves, a novel intermediate useful for synthesis thereof and processes for preparing the same are disclosed.|
|Inventor(s):||Tamura; Yasumitsu (Takarazuka, JA), Nakagawa; Kazuyuki (Tokushima, JA), Yoshizaki; Shiro (Komatsujima, JA), Murakami; Nanami (Tokushima, JA)|
|Assignee:||Otsuka Pharmaceutical (Tokyo, JA)|
Patent Claim Types:|
see list of patent claims
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|Argentina||197270||<disabled in preview>|
|Argentina||209575||<disabled in preview>|
|Austria||A244373||<disabled in preview>|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.